67 related articles for article (PubMed ID: 28425274)
1. Profile of POT1 as telomerase shelterin component discriminatesbetween cervical cancer and normal cervical cells.
Wijaya AB; Hidayatullah F; Setyabudhi VV; Pahlevi FR; Indra R; Nurseta T
Turk J Med Sci; 2017 Apr; 47(2):417-423. PubMed ID: 28425274
[TBL] [Abstract][Full Text] [Related]
2. Expression of telomere binding proteins in gastric cancer and correlation with clinicopathological parameters.
Gao J; Zhang J; Long Y; Lu X
Asia Pac J Clin Oncol; 2011 Dec; 7(4):339-45. PubMed ID: 22151982
[TBL] [Abstract][Full Text] [Related]
3. Time-Dependent Effects of POT1 Knockdown on Proliferation, Tumorigenicity, and HDACi Response of SK-OV3 Ovarian Cancer Cells.
Zhou H; Mondal A; Dakic A; Alhawas L; Liu X; He Z
Biomed Res Int; 2018; 2018():7184253. PubMed ID: 29546066
[TBL] [Abstract][Full Text] [Related]
4. A balanced transcription between telomerase and the telomeric DNA-binding proteins TRF1, TRF2 and Pot1 in resting, activated, HTLV-1-transformed and Tax-expressing human T lymphocytes.
Escoffier E; Rezza A; Roborel de Climens A; Belleville A; Gazzolo L; Gilson E; Duc Dodon M
Retrovirology; 2005 Dec; 2():77. PubMed ID: 16354306
[TBL] [Abstract][Full Text] [Related]
5. TPP1 is associated with risk of advanced precursors and cervical cancer survival.
Wang QL; Gong C; Meng XY; Fu M; Yang H; Zhou F; Wu Q; Zhou Y
PLoS One; 2024; 19(5):e0298118. PubMed ID: 38722833
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions.
Nagai N; Oshita T; Murakami J; Ohama K
Oncol Rep; 1999; 6(2):325-8. PubMed ID: 10022998
[TBL] [Abstract][Full Text] [Related]
7. Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer.
Widschwendter A; Müller HM; Hubalek MM; Wiedemair A; Fiegl H; Goebel G; Mueller-Holzner E; Marth C; Widschwendter M
Gynecol Oncol; 2004 May; 93(2):407-16. PubMed ID: 15099954
[TBL] [Abstract][Full Text] [Related]
8. Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro.
Kelleher C; Kurth I; Lingner J
Mol Cell Biol; 2005 Jan; 25(2):808-18. PubMed ID: 15632080
[TBL] [Abstract][Full Text] [Related]
9. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
[TBL] [Abstract][Full Text] [Related]
10. Activation of telomerase by seminal plasma in malignant and normal cervical epithelial cells.
Liu L; Liu C; Lou F; Zhang G; Wang X; Fan Y; Yan K; Wang K; Xu Z; Hu S; Björkholm M; Xu D
J Pathol; 2011 Oct; 225(2):203-11. PubMed ID: 21590772
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase activity in cervical intraepithelial neoplasia].
Wang S; Sun J; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2001 May; 36(5):275-7. PubMed ID: 11783375
[TBL] [Abstract][Full Text] [Related]
12. Implication of human telomerase reverse transcriptase in cervical carcinogenesis and cancer recurrence.
Wang PH; Ko JL
Int J Gynecol Cancer; 2006; 16(5):1873-9. PubMed ID: 17009985
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.
Oikonomou P; Messinis I; Tsezou A
Exp Biol Med (Maywood); 2007 Jul; 232(7):881-6. PubMed ID: 17609503
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid inhibits telomerase activity and downregulates expression but does not affect splicing of hTERT: correlation with cell growth rate inhibition in an in vitro cervical carcinogenesis/multidrug-resistance model.
Ding Z; Green AG; Yang X; Chernenko G; Tang SC; Pater A
Exp Cell Res; 2002 Jan; 272(2):185-91. PubMed ID: 11777343
[TBL] [Abstract][Full Text] [Related]
16. Concomitant underexpression of TGFBR2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
[TBL] [Abstract][Full Text] [Related]
17. The telomere proteins in tumorigenesis and clinical outcomes of oral squamous cell carcinoma.
Benhamou Y; Picco V; Pagès G
Oral Oncol; 2016 Jun; 57():46-53. PubMed ID: 27208844
[TBL] [Abstract][Full Text] [Related]
18. Telomerase RNA stem terminus element affects template boundary element function, telomere sequence, and shelterin binding.
Webb CJ; Zakian VA
Proc Natl Acad Sci U S A; 2015 Sep; 112(36):11312-7. PubMed ID: 26305931
[TBL] [Abstract][Full Text] [Related]
19. PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells.
Wu G; Liu D; Jiang K; Zhang L; Zeng Y; Zhou P; Zhong D; Gao M; He F; Zheng Y
Biochim Biophys Acta; 2014 Feb; 1839(2):88-96. PubMed ID: 24412852
[TBL] [Abstract][Full Text] [Related]
20. Modulation of telomere shelterin by TRF1 [corrected] and TRF2 interacts with telomerase to maintain the telomere length in non-small cell lung cancer.
Hsu CP; Ko JL; Shai SE; Lee LW
Lung Cancer; 2007 Dec; 58(3):310-6. PubMed ID: 17681636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
